Symbiotic cardiac pacemaker

Nat Commun. 2019 Apr 23;10(1):1821. doi: 10.1038/s41467-019-09851-1.

Abstract

Self-powered implantable medical electronic devices that harvest biomechanical energy from cardiac motion, respiratory movement and blood flow are part of a paradigm shift that is on the horizon. Here, we demonstrate a fully implanted symbiotic pacemaker based on an implantable triboelectric nanogenerator, which achieves energy harvesting and storage as well as cardiac pacing on a large-animal scale. The symbiotic pacemaker successfully corrects sinus arrhythmia and prevents deterioration. The open circuit voltage of an implantable triboelectric nanogenerator reaches up to 65.2 V. The energy harvested from each cardiac motion cycle is 0.495 μJ, which is higher than the required endocardial pacing threshold energy (0.377 μJ). Implantable triboelectric nanogenerators for implantable medical devices offer advantages of excellent output performance, high power density, and good durability, and are expected to find application in fields of treatment and diagnosis as in vivo symbiotic bioelectronics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arrhythmia, Sinus / etiology
  • Arrhythmia, Sinus / surgery*
  • Cardiac Surgical Procedures / instrumentation
  • Cardiac Surgical Procedures / methods
  • Cell Line
  • Dimethylpolysiloxanes / chemistry
  • Disease Models, Animal
  • Electrophysiological Phenomena*
  • Equipment Design
  • Heart / physiology*
  • Male
  • Mice
  • Nanomedicine / instrumentation*
  • Nanomedicine / methods
  • Nylons / chemistry
  • Pacemaker, Artificial*
  • Polytetrafluoroethylene / chemistry
  • Prosthesis Implantation / instrumentation
  • Prosthesis Implantation / methods
  • Sus scrofa

Substances

  • Dimethylpolysiloxanes
  • Nylons
  • poly(dimethylsiloxane)-polyamide copolymer
  • Polytetrafluoroethylene